Select Publications
Conference Posters
2022, 'The trends and opinions of Australian clinicians on the use of antihyperglycemic agents in heart failure patients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2022 - 29 November 2019
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at American Conference on Pharmacometrics, Virtual, 08 November 2021 - 12 November 2021
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at IATDMCT, Virtual, 19 September 2021 - 22 September 2021
,2021, 'Matters close to the heart: adaptation of a tacrolimus model to inform therapeutic drug monitoring using the PRIOR approach', Virtual, presented at Population Approach Group Europe, Virtual, 02 September 2021 - 07 September 2021
,2020, 'Predictive performance of population pharmacokinetic models for tacrolimus in lung transplant recipients', Virtual, presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020
,2020, 'A step forward in patient safety - understanding barriers to correct intravenous medication administrations', Virtual, presented at ASCEPT, Virtual, 29 November 2020 - 02 December 2020
,2020, 'External evaluation of population pharmacokinetic models of tacrolimus in adult heart transplant recipients', presented at Pharmacometrics Japan, 22 January 2020 - 23 January 2020
,2019, 'Accuracy of documented administration times for intravenous antimicrobial drugs', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Barriers and facilitators to user acceptance of a pilot therapeutic drug monitoring advisory service for vancomycin', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'External evaluation of published population pharmacokinetic models of tacrolimus in adult heart transplant recipients', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review', Queenstown, New Zealand, presented at ASCEPT-PAGANZ, Queenstown, New Zealand, 25 November 2019 - 29 November 2019
,2019, 'Designing a therapeutic drug monitoring (TDM) advisory service for vancomycin: identifying barriers and facilitators to service implementation', Darwin, Australia, presented at ASID, Darwin, Australia, 16 May 2019 - 18 May 2019
,2019, 'Predictive performance of a commercial Bayesian forecasting program in estimating vancomycin drug exposure', Washington DC, USA, presented at American Society for Clinical Pharmacology and Therapeutics, Washington DC, USA, 14 March 2019 - 16 March 2019
,2018, 'Comparison of vancomycin area-under-the-curve using one and two-compartment pharmacokinetic models', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Predictive performance of tacrolimus precision dosing software', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Tacrolimus Dosing and Monitoring in Lung Transplant Patients', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Tacrolimus dosing and monitoring: a retrospective cohort study', Adelaide, Australia, presented at ASCEPT, Adelaide, Australia, 27 November 2018 - 30 November 2018
,2018, 'Understanding amikacin, are we hitting the mark?', Brisbane, Australia, presented at IATDMCT, Brisbane, Australia, 16 September 2018 - 19 September 2018
,2017, 'A Multicentre Open-Label Pharmacokinetic-Pharmacodynamic Study of Febuxostat in Patients with Chronic Gout', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'A time and motion study of phlebotomists’ work', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'Education for vancomycin – what works?', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety and Pharmacokinetics of Metformin in Heart Failure', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'The Safety of Metformin in Haemodiafiltration', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2017, 'Therapeutic drug monitoring of voriconazole', Brisbane, Australia, presented at APSA-ASCEPT, Brisbane, Australia, 05 December 2017 - 08 December 2017
,2016, 'Exploring the barriers and facilitators of vancomycin guideline compliance', Melbourne, Australia, presented at ASCEPT-MPGPCR Joint Scientific Meeting, Melbourne, Australia, 27 November 2016 - 30 November 2016
,2009, 'Do divalent cations increase the anion-cation permeability in glycine receptor channels, even with initial offset and activity corrections?', Japan, pp. 393 - 393, presented at 36th International Congress of Physiological Sciences, Kyoto, Japan, 27 July 2009 - 01 August 2009
,2009, 'Molecular determinants of ion permeation in glycine receptor-channels: characterising charged residues in the intracellular M3-M4 loop', Kyoto, Japan, Vol. 59, pp. 393 - 393, presented at 36th International Congress of Physiological Societies, Kyoto, Japan, 27 July 2009 - 01 August 2009
,